InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
6
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+0.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Benathen Marc David, Chief Financial Officer. Insider active across 2 companies, notably LifeMD, Inc.. Aggregated, 13 filings have been published. Split: 6 buys · 0 sell. Total volume traded: €89k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 22 August 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations13 total
87,000 shares0Common StockSEC:0000912282-25-000910:0
75,000 shares0Common StockSEC:0000912282-25-000361:0
87,000 shares0Common StockSEC:0000912282-25-000281:0
75,000 shares0Common StockSEC:0001362118-24-000009:0
25,000 shares0Common StockSEC:0001362118-23-000047:0
25,000 shares0Common StockSEC:0001362118-22-000005:0
25,000 shares0Common StockSEC:0001362118-22-000005
7,831 shares@ US$4.090.017% mcap35.1% of flowCommon Stock, par value $0.01SEC:0001362118-21-000049:0
Ideal exit: 27 Aug 2022 (T+270)
7,831 shares@ US$4.0935.1% of flowCommon Stock, par value $0.01SEC:0001362118-21-000049
Ideal exit: 27 Aug 2022 (T+270)
1,297 shares@ US$7.230.0049% mcap9.9% of flowCommon StockSEC:0001362118-21-000029:0
Ideal exit: 15 May 2022 (T+270)
1,297 shares@ US$7.239.9% of flowCommon StockSEC:0001362118-21-000029
Ideal exit: 15 May 2022 (T+270)
1,099 shares@ US$8.9334100.0% of flowCommon StockSEC:0001362118-21-000010
Ideal exit: 13 Feb 2022 (T+270)
1,099 shares@ US$8.93340.0049% mcap10.0% of flowCommon StockSEC:0001362118-21-000010:0
Ideal exit: 13 Feb 2022 (T+270)
13 of 13 declarations
About Benathen Marc David
Marc David Benathen is the Chief Financial Officer of LifeMD, Inc. and LifeMD, Inc. He oversees all financial operations of the company, including financial planning, reporting, and compliance. In his role, Marc ensures that LifeMD maintains high standards of financial integrity and transparency. His experience in finance is crucial to support LifeMD's growth strategy.
